Jiangsu Aidea Pharmaceutical's board of directors has released a statement regarding the stock price fluctuations prior to the first disclosure of the restructuring plan.

SZSI · Jun 26

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.